SGMO Financial Facts

Basic and diluted net loss per share: -0.17
Loss from operations: -12.28M
See Full Income Statement

Commitments and contingencies: 0
Accumulated other comprehensive income / (loss): -3K
See Full Balance Sheet

Sangamo Biosciences Inc. (SGMO) Earnings

  |   Expand Research on SGMO
Next EPS Date 10/22/15 *Est. EPS Growth Rate -70.0% *Last Qtr.
Average EPS % Beat Rate +16.7% Revenue Growth Rate -19.2% *Last Qtr.
Average % Move 1-Wk after EPS +3.1% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/5/15 Q215 -$0.17-$0.13 -$0.04$8.4M$14.72M = Details
4/22/15 Q115 -$0.08-$0.14 +$0.06$13.5M$12.5M = Details
2/10/15 Q414 -$0.06-$0.09 +$0.03$14.95M$14.5M = Details
10/22/14 Q314 -$0.11-$0.14 +$0.03$12.4M$8.27M = Details
7/23/14 Q214 -$0.10-$0.14 +$0.04$10.4M$7.84M = Details
5/6/14 Q114 -$0.12-$0.13 +$0.01$8.1M$6.59M = Details
2/11/14 Q413 -$0.13N/A N/A $6.9M$8.9M = Details
10/23/13 Q313 -$0.11-$0.11 $0.00$5.7M$5.52M = Details